Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.

Chan, S C

Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. [electronic resource] - The Journal of investigative dermatology May 1993 - 681-4 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0022-202X

10.1111/1523-1747.ep12472344 doi


4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone--pharmacology
Adult
Cyclic AMP--metabolism
Dermatitis, Atopic--metabolism
Humans
Interleukin-4--antagonists & inhibitors
Monocytes--metabolism
Phosphodiesterase Inhibitors--pharmacology
Phosphoric Diester Hydrolases--metabolism
Reference Values